Ji L - Search Results

1

Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging.

Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, Holmes DR, Sposto R, Sener SF. Valente SA, et al. Among authors: ji l. Ann Surg Oncol. 2012 Jun;19(6):1825-30. doi: 10.1245/s10434-011-2200-7. Epub 2012 Jan 7. Ann Surg Oncol. 2012. PMID: 22227922

2

Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.

Keshelava N, Davicioni E, Wan Z, Ji L, Sposto R, Triche TJ, Reynolds CP. Keshelava N, et al. Among authors: ji l. J Natl Cancer Inst. 2007 Jul 18;99(14):1107-19. doi: 10.1093/jnci/djm044. Epub 2007 Jul 10. J Natl Cancer Inst. 2007. PMID: 17623797

3

Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.

Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S. Fangusaro J, et al. Among authors: ji l. Pediatr Blood Cancer. 2008 Feb;50(2):312-8. doi: 10.1002/pbc.21307. Pediatr Blood Cancer. 2008. PMID: 17668858 Clinical Trial.

4

Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity.

Harned TM, Kalous O, Neuwelt A, Loera J, Ji L, Iovine P, Sposto R, Neuwelt EA, Reynolds CP. Harned TM, et al. Among authors: ji l. Clin Cancer Res. 2008 Jan 15;14(2):533-40. doi: 10.1158/1078-0432.CCR-06-2289. Clin Cancer Res. 2008. PMID: 18223229

5

Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.

Dhall G, Grodman H, Ji L, Sands S, Gardner S, Dunkel IJ, McCowage GB, Diez B, Allen JC, Gopalan A, Cornelius AS, Termuhlen A, Abromowitch M, Sposto R, Finlay JL. Dhall G, et al. Among authors: ji l. Pediatr Blood Cancer. 2008 Jun;50(6):1169-75. doi: 10.1002/pbc.21525. Pediatr Blood Cancer. 2008. PMID: 18293379 Clinical Trial.

6

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML. Ko RH, et al. Among authors: ji l. J Clin Oncol. 2010 Feb 1;28(4):648-54. doi: 10.1200/JCO.2009.22.2950. Epub 2009 Oct 19. J Clin Oncol. 2010. PMID: 19841326 Free PMC article.

7

Central nervous system (CNS) tumors in the first six months of life: the Children's Hospital Los Angeles experience, 1979-2005.

Serowka K, Chiu Y, Gonzalez I, Gilles F, McComb G, Krieger M, Dhall G, Britt B, Ji L, Sposto R, Finlay JL. Serowka K, et al. Among authors: ji l. Pediatr Hematol Oncol. 2010 Mar;27(2):90-102. doi: 10.3109/08880010903447342. Pediatr Hematol Oncol. 2010. PMID: 20201690

8

Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. van Doorninck JA, et al. Among authors: ji l. J Clin Oncol. 2010 Apr 20;28(12):1989-94. doi: 10.1200/JCO.2009.24.5845. Epub 2010 Mar 22. J Clin Oncol. 2010. PMID: 20308669 Free PMC article.

9

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Gorman MF, Ji L, Ko RH, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML. Gorman MF, et al. Among authors: ji l. Pediatr Blood Cancer. 2010 Sep;55(3):421-9. doi: 10.1002/pbc.22612. Pediatr Blood Cancer. 2010. PMID: 20658611

10

Activity of irinotecan and temozolomide in the presence of O6-methylguanine-DNA methyltransferase inhibition in neuroblastoma pre-clinical models.

Cai W, Maldonado NV, Cui W, Harutyunyan N, Ji L, Sposto R, Reynolds CP, Keshelava N. Cai W, et al. Among authors: ji l. Br J Cancer. 2010 Oct 26;103(9):1369-79. doi: 10.1038/sj.bjc.6605927. Epub 2010 Oct 5. Br J Cancer. 2010. PMID: 20924375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,440 results

Search Page

Filters